Aflurax
DrugOther names: Pectin-containing nature product
NCT Number: NCT00184522
A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Gjøvik Specialist Centre, Gjøvik, Norway
A randomized, controlled, open trial comparing the symptomatic effect of a pectin-containing product (Aflurax) with that of esomeprazole (Nexium 20 mg) given on-demand for 6 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Mild and moderate reflux symptoms Age > 17 years Informed consent -
Exclusion criteria
Other conditions that might explain the symptoms Abuse of drugs or alcohol
-
Other names: Pectin-containing nature product
Other names: Nexium
Looking for future studies?
Notify MeNorwegian University of Science and Technology
Other
Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00300755
Deglutition Disorders, Digestive System Diseases
Mobile, Alabama, United States
View Trial DetailsNCT01136317
Deglutition Disorders, Digestive System Diseases
Nantes, France
View Trial DetailsNCT05556824
Deglutition Disorders, Digestive System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03596411
Deglutition Disorders, Digestive System Diseases
Nice, Alpes Maritimes, France
View Trial Details